GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » Net Change in Cash

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Net Change in Cash : ¥75 Mil (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Shandong Xinhua Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥7 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥75 Mil.

Shandong Xinhua Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co Net Change in Cash Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -109.62 144.94 -126.17 414.37 -229.08

Shandong Xinhua Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -297.25 140.79 -152.58 79.96 6.56

Shandong Xinhua Pharmaceutical Co Net Change in Cash Calculation

Shandong Xinhua Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=265.279+-305.109+-196.11+6.859
=-229

Shandong Xinhua Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=38.063+-52.475+16.789+4.186
=7

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Xinhua Pharmaceutical Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » Net Change in Cash
Comparable Companies
SZSE:000650 SZSE:002038 SHSE:600976 SZSE:002020 SHSE:600993 SHSE:600216 SHSE:600267 SZSE:002332 SZSE:002099 SZSE:002755 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ
Traded in Other Exchanges
00719:Hong Kong XIN:Germany
Address
No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086
Website
http://www.xhzy.com
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Headlines

No Headlines